Symbol="MIRM"
AssetType="Common Stock"
Name="Mirum Pharmaceuticals Inc"
Description="Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver diseases. The company is headquartered in Foster City, California."
CIK="1759425"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="950 TOWER LANE, SUITE 1050, FOSTER CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1015845000"
EBITDA="-121399000"
PERatio="None"
PEGRatio="None"
BookValue="3.713"
DividendPerShare="0"
DividendYield="0"
EPS="-3.65"
RevenuePerShareTTM="2.703"
ProfitMargin="-1.349"
OperatingMarginTTM="-1.312"
ReturnOnAssetsTTM="-0.257"
ReturnOnEquityTTM="-1.033"
RevenueTTM="95768000"
GrossProfitTTM="64688000"
DilutedEPSTTM="-3.65"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.451"
AnalystTargetPrice="54.43"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="12.6"
PriceToBookRatio="3.955"
EVToRevenue="9.3"
EVToEBITDA="-16.18"
Beta="1.266"
num_52WeekHigh="30.55"
num_52WeekLow="17.32"
num_50DayMovingAverage="26.92"
num_200DayMovingAverage="23.09"
SharesOutstanding="38031800"
DividendDate="None"
ExDividendDate="None"
symbol="MIRM"
open="26.65"
high="26.81"
low="26.12"
price="26.30"
volume="771893.00"
latest_trading_day="2023-07-12"
previous_close="26.61"
change="-0.31"
change_percent="-1.1650%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="495782"
Change_recent_avg="0.07"
Delta_recent_avg="1.11"
Variance_recent_avg="0.55"
Change_ratio_recent_avg="0.25"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="110"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0066.jpeg"
image_negative_thumbnail_id_2="1142"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0175.jpeg"
image_neutral_thumbnail_id_1="526"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_neutral_thumbnail_id_2="576"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_positive_thumbnail_id_1="624"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0084.jpeg"
image_positive_thumbnail_id_2="974"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0136.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
